| Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS M DeJesus-Hernandez, IR Mackenzie, BF Boeve, AL Boxer, M Baker, ... Neuron 72 (2), 245-256, 2011 | 5271 | 2011 |
| Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing BW Kunkle, B Grenier-Boley, R Sims, JC Bis, V Damotte, AC Naj, ... Nature genetics 51 (3), 414-430, 2019 | 2166 | 2019 |
| Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease AC Naj, G Jun, GW Beecham, LS Wang, BN Vardarajan, J Buros, ... Nature genetics 43 (5), 436-441, 2011 | 2134 | 2011 |
| Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria GU Höglinger, G Respondek, M Stamelou, C Kurz, KA Josephs, AE Lang, ... Movement disorders 32 (6), 853-864, 2017 | 1664 | 2017 |
| Criteria for the diagnosis of corticobasal degeneration MJ Armstrong, I Litvan, AE Lang, TH Bak, KP Bhatia, B Borroni, AL Boxer, ... Neurology 80 (5), 496-503, 2013 | 1659 | 2013 |
| Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins S Ray, M Britschgi, C Herbert, Y Takeda-Uchimura, A Boxer, K Blennow, ... Nature medicine 13 (11), 1359-1362, 2007 | 1277 | 2007 |
| ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy Y Shi, K Yamada, SA Liddelow, ST Smith, L Zhao, W Luo, RM Tsai, ... Nature 549 (7673), 523-527, 2017 | 977 | 2017 |
| Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ... Nature genetics 49 (9), 1373-1384, 2017 | 898 | 2017 |
| Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: a case‐control study MS Fiandaca, D Kapogiannis, M Mapstone, A Boxer, E Eitan, JB Schwartz, ... Alzheimer's & Dementia 11 (6), 600-607. e1, 2015 | 796 | 2015 |
| At the interface of sensory and motor dysfunctions and Alzheimer's disease MW Albers, GC Gilmore, J Kaye, C Murphy, A Wingfield, DA Bennett, ... Alzheimer's & Dementia 11 (1), 70-98, 2015 | 557 | 2015 |
| Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis C Bridel, WN Van Wieringen, H Zetterberg, BM Tijms, CE Teunissen, ... JAMA neurology 76 (9), 1035-1048, 2019 | 542 | 2019 |
| Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration EH Thijssen, R La Joie, A Wolf, A Strom, P Wang, L Iaccarino, ... Nature medicine 26 (3), 387-397, 2020 | 520 | 2020 |
| Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes G Jun, AC Naj, GW Beecham, LS Wang, J Buros, PJ Gallins, JD Buxbaum, ... Archives of neurology 67 (12), 1473-1484, 2010 | 496 | 2010 |
| Clinicopathological correlations in corticobasal degeneration SE Lee, GD Rabinovici, MC Mayo, SM Wilson, WW Seeley, SJ DeArmond, ... Annals of neurology 70 (2), 327-340, 2011 | 450 | 2011 |
| Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease EJ Goetzl, A Boxer, JB Schwartz, EL Abner, RC Petersen, BL Miller, ... Neurology 85 (1), 40-47, 2015 | 422 | 2015 |
| Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons S Almeida, E Gascon, H Tran, HJ Chou, TF Gendron, S DeGroot, ... Acta neuropathologica 126, 385-399, 2013 | 394 | 2013 |
| Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy AL Boxer, MD Geschwind, N Belfor, ML Gorno-Tempini, GF Schauer, ... Archives of neurology 63 (1), 81-86, 2006 | 369 | 2006 |
| Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation S Villeneuve, GD Rabinovici, BI Cohn-Sheehy, C Madison, N Ayakta, ... Brain 138 (7), 2020-2033, 2015 | 368 | 2015 |
| Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches AL Boxer, JT Yu, LI Golbe, I Litvan, AE Lang, GU Höglinger The Lancet Neurology 16 (7), 552-563, 2017 | 356 | 2017 |
| Discriminative accuracy of [18F] flortaucipir positron emission tomography for Alzheimer disease vs other neurodegenerative disorders R Ossenkoppele, GD Rabinovici, R Smith, H Cho, M Schöll, O Strandberg, ... Jama 320 (11), 1151-1162, 2018 | 353 | 2018 |
